- Joined
- Sep 2, 2024
- Messages
- 583
- Reaction score
- 1,397
Novo's semaglutide among 2nd batch of drugs selected for Medicare price negotiation
Here are the first two sentences of the article:
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction Act.
The list of 15 medicines includes blockbuster drugs from Novo Nordisk, Pfizer, Bristol Myers Squibb, AstraZeneca, GSK and other companies. Novo’s booming semaglutide franchise for diabetes and obesity is the standout inclusion in this year’s list.
Here are the first two sentences of the article:
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction Act.
The list of 15 medicines includes blockbuster drugs from Novo Nordisk, Pfizer, Bristol Myers Squibb, AstraZeneca, GSK and other companies. Novo’s booming semaglutide franchise for diabetes and obesity is the standout inclusion in this year’s list.